Daniel Tarockoff - Regenerative Capital: Novel Financing and Mainstreaming from a VC's Perspective

Venture capital in the psychedelic space is increasingly focused on finding alternative financing models that align incentives with long-term societal well-being. Traditional venture funding often exerts pressure on companies to accelerate drug development and prioritize high-margin commercialization which can lead to a dystopian and hyper-medicalized reality. Regenerative capital, as piloted by funds like Vine Ventures, seeks to mitigate these risks. By utilizing special purpose vehicles and revenue share agreements, such approaches avoid the short-term pressures of equity ownership. These flexible models can be used to fund open-source initiatives or clinical development while ensuring long-term returns are shared back with the community and nonprofit sectors, thereby prioritizing public interest alongside commercial success.